Cat Not Eating After Fluids: What CKD Owners Should Know

If your CKD cat finishes a subcutaneous fluid session and then refuses dinner, you are not alone, and you are not necessarily doing anything wrong. This is a plain-English guide to what is happening, what works to fix it, and when refusal becomes an emergency. Anchored to ISFM, IRIS, and peer-reviewed feline medicine literature.

Why CKD cats stop eating

For decades, cat owners were told that CKD cats stop eating because uremic toxins cause stomach ulcers. The actual evidence in cats says otherwise.

McLeland and colleagues conducted a prospective post-mortem study of 37 CKD cats compared with 12 non-azotemic controls (JVIM 2014) [2]. The findings:

• Gastric mucosal mineralization in 38 percent of CKD cats.
• Gastric fibrosis in 43 percent.
• No ulceration, no edema, no vascular fibrinoid change, no hemorrhage.
• Hypergastrinemia did not correlate with CKD severity.

What is actually happening in cats: uremic toxins act centrally on the chemoreceptor trigger zone (CRTZ) in the brain. ISFM states it directly: "Cats with CKD can suffer from nausea, vomiting and inappetence as a result of uraemic toxins affecting the central chemoreceptor trigger zone" [1]. The treatment implication is significant. If the problem were ulcers, antacids would help. The problem is brain-mediated nausea, so antiemetics that block the CRTZ (maropitant, ondansetron) work.

Three other contributors:

• Anemia. Lack of red blood cells produces lethargy and poor appetite. Cornell: "Lack of red blood cells will cause cats to feel very lethargic, have a poor appetite, and have pale or white gums" [3].
• Hypokalemia, metabolic acidosis, dehydration. All worsen uremia and inappetence. ISFM advises correcting these before assuming progressive disease [1].
• Loss of nutrients in urine. Cornell notes that "loss of important proteins and vitamins in their urine may contribute to abnormal metabolism and loss of appetite" [3].

Is loss of appetite after SC fluids normal?

The honest answer: there is no peer-reviewed evidence that SC fluids themselves cause persistent inappetence. ISFM and Cornell both endorse SC fluids as supportive care for advanced CKD, and neither describes post-fluid anorexia as a recognized adverse effect [1, 3].

What can plausibly happen short-term:

• Cold fluids straight from storage feel uncomfortable. Warming the bag to body temperature dramatically improves tolerance (see our SC fluids schedule page).
• The subcutaneous fluid bubble can feel strange. Most cats settle within 30 to 60 minutes.
• The session itself was stressful and the cat is in fight-or-flight mode. Appetite resumes once they relax.

What is not normal: persistent refusal lasting 24 hours or more after a fluid session. That points to underlying uremia or electrolyte problems and should be addressed by your vet, not blamed on the fluids.

Conversely, withholding fluids when a cat is dehydrated also worsens inappetence. Dehydration drives uremia, which drives nausea, which drives food refusal. ISFM lists correction of dehydration as a primary supportive measure precisely because it improves uremic signs including appetite [1].

The red-flag threshold (when to call the vet)

The first-line treatment: Mirataz (transdermal mirtazapine)

Mirataz was FDA-approved in May 2018 as the first transdermal mirtazapine for cats, indicated for management of weight loss [7]. The dose is straightforward: a 1.5-inch ribbon (2 mg) of ointment, applied to the inner ear once daily for 14 days. Wear gloves.

The efficacy data are strong. Quimby et al. (JFMS 2020) ran a double-blind placebo-controlled crossover trial in client-owned IRIS Stage 2 to 3 CKD cats [5]. Compounded transdermal mirtazapine produced:

• Statistically significant increase in appetite (P = 0.005).
• Increased rate of food consumption (P = 0.008).
• Body condition score improvement in 6 of 10 cats (P = 0.004).
• Median weight gain of 0.26 kg (P = 0.002).

Older oral mirtazapine evidence also showed efficacy as both appetite stimulant and antiemetic [8]. For most CKD cats with inappetence, Mirataz is the first thing your vet will reach for.

The newer option: Elura (capromorelin)

Elura was FDA-approved in October 2020 as the first drug indicated specifically for "management of weight loss in cats with chronic kidney disease" [9]. It is an oral solution at 20 mg/mL, dosed at 2 mg/kg (0.1 mL/kg) once daily. Offer food about 30 minutes after dosing. If the cat vomits within 15 minutes of the dose, redose.

Mechanism: capromorelin is a selective ghrelin receptor agonist. It binds hypothalamic ghrelin receptors to stimulate appetite and pituitary ghrelin receptors to release growth hormone, raising IGF-1 to support weight gain [9].

The pivotal trial, n = 176 CKD cats with at least 5 percent weight loss, randomized and placebo-controlled, showed capromorelin-treated cats gained a least-squares mean of 5.2 percent body weight over 56 days versus placebo [9, 10].

The side-effect profile is harsher than Mirataz: vomiting 29.6 percent, hypersalivation 21.2 percent, decreased appetite 18.6 percent, behavior change, lethargy [9]. Caution in cats with diabetes, cardiac disease, severe dehydration, or hepatic dysfunction. Contraindicated in hypersomatotropism (acromegaly). For some cats this works dramatically; for others the side effects are intolerable.

The anti-nausea: Cerenia (maropitant)

Maropitant is an NK1 receptor antagonist that blocks substance P at the chemoreceptor trigger zone. The FDA-approved feline indication (2012) is for treatment of vomiting, at 1 mg/kg SC once daily for up to 5 consecutive days [11].

Off-label chronic use in CKD has peer-reviewed support, but for vomiting only, not for appetite. Quimby et al. (JFMS 2015) ran a blinded placebo-controlled trial of oral maropitant in CKD cats [12]:

• Vomiting was significantly reduced (P less than 0.01, median episodes 0 versus 2).
• No statistically significant difference in appetite or activity.
• No weight gain.

The clinical implication: maropitant alone is not an appetite stimulant. It palliates vomiting. The standard combination for the CKD cat with nausea and inappetence is maropitant plus mirtazapine (or capromorelin) to address both axes. Merck Veterinary Manual explicitly endorses this layered approach [13].

What about phosphate binders and renal diet

Phosphate binders MUST be given with food, not separately. The mechanism is binding dietary phosphate in the GI tract, so giving binders between meals is pharmacologically inactive [1]. If your cat is refusing food and the binder routine has fallen apart, that is normal. The fix is to recover appetite first; the binder rejoins once the cat is eating.

Renal diets are less palatable than maintenance diets [1]. Fritsch and Allen (Vet Record Open 2015) found 94 percent of cats transitioned successfully over 10 to 14 days, with 89 percent rated as liking the diet when transitioned correctly [14]. The single biggest mistake owners make: introducing the renal diet only after the cat is already inappetent. The right time is at IRIS Stage 2 diagnosis, while the cat is still eating well, with a gradual mix over 2 to 4 weeks.

Aldrich et al. compared five palatability supplements in CKD cats; warming food slightly, adding low-phosphorus toppers, and varying texture (pâté versus chunk) can recover acceptance without abandoning the renal diet [15].

The hydration check (and why skin tent fails in old cats)

Owner-facing hydration assessment is harder than the literature implies. The classic signs are skin turgor and mucous membrane moisture, but skin tent is unreliable in older cats because their subcutaneous tissue has lost elasticity. A geriatric cat can show a "positive" skin tent even when fully hydrated [1].

Better at-home checks:

• Gum moisture. Run a clean finger over the gum. Should feel wet, not tacky.
• Weekly weight on the same kitchen scale. A 0.1 kg drop in a 4 kg cat is meaningful.
• Water intake tracked daily. A sudden change up or down is a flag.
• Eye position. Sunken eyes in a normally bright-eyed cat suggest dehydration.

Capillary refill time is sometimes recommended online, but it is a circulation indicator, not a hydration check. Save it for shock signs. Bloodwork is what definitively confirms hydration status, and your vet runs it.

Force-feeding versus feeding tubes

The instinct is to syringe-feed when the cat will not eat. The current evidence says do not.

The 2022 ISFM Inappetent Hospitalised Cat Consensus is explicit: persistent force-feeding induces food aversion and stress, paradoxically worsening long-term intake [6]. Owners who syringe-feed a CKD cat for weeks often end up with a cat that associates food with restraint and refuses even palatable options.

The published alternative: esophagostomy feeding tubes (E-tubes), placed earlier rather than later [16]. ISFM frames E-tubes as "more physiological" than chronic SC fluids for hydration in advanced disease, and they support nutritional needs concurrently. Indications include inability to maintain body condition on voluntary intake despite appetite stimulants and antiemetics [1].

The standard escalation order

1. Correct the basics first. Dehydration, hypokalemia, anemia, metabolic acidosis. ISFM and IRIS both recommend this before assuming progressive uremia [1, 4].
2. Add an antiemetic if vomiting or nausea is present. Maropitant 1 mg/kg subcutaneously, or oral. For chronic nausea, ondansetron is another option [12, 13].
3. Add an appetite stimulant. Mirataz transdermal for most cats; Elura for cats whose CKD is the primary driver and who can tolerate the higher GI side-effect profile [5, 9].
4. Consider an E-tube if appetite stimulants are not enough to maintain body condition [16].

Tracking inappetence so your vet sees the pattern

Two missed meals across three weeks looks different from two missed meals across three days. Reconstructing that from memory at the vet visit is hard. A daily log is what makes the difference between "appetite seems off lately" and "she has eaten less than 50 grams a day for the last 11 days."

Remewdy is a free iPhone app that logs each meal (or skipped meal), each SC fluid session, each medication, and each weight check in one tap. Premium users print a PDF summary for the vet that combines the entire pattern. The compliance heat map shows the last 4 to 12 weeks at a glance.

The app does not prescribe Mirataz or Elura, set an E-tube indication, or interpret bloodwork. It does the boring part: keeping the record straight so your vet can do the medical part well.